LSE · PLUS.L
Plus500 Ltd.
£33.06-£0.58 (-1.72%)
Plus500 Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.27% below the high.
Loading market information…
TLV · AMDA.TA · ILA
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 09:48 AM UTC. Cached market data; not a live quote.
One-year closing-price history · ILA. Historical prices are not a forecast.
Almeda Ventures Limited Partnership’s quoted price sits in the upper half of its reported 52-week range, 12.08% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Almeda Ventures Limited Partnership’s forward annual dividend is ₪1.22 per share, paid quarterly. The forward yield is 45.08% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Almeda Ventures Limited Partnership’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Almeda Ventures Limited Partnership, established in Tel Aviv, Israel, in 2020, functions as a venture capital firm. The partnership strategically deploys capital across various development stages, including seed, startup, early-stage, and established middle-market companies. Its core investment thesis centers on health technology innovation, with a particular emphasis on medical devices, digital health solutions, bio-convergence, and public R&D collaborations. Additionally, Almeda Ventures allocates funds to life sciences research and development enterprises. Geographically, the firm primarily focuses its investments within Israel, the United States, and Europe.
Latest available per-share figures in ILS. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
£33.06-£0.58 (-1.72%)
Plus500 Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.27% below the high.
$23.37-$0.24 (-1.02%)
eToro Group Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.14% below the high.
₪3.20₪0.00 (0.0%)
Endymed Ltd’s quoted price sits in the upper half of its reported 52-week range, 9.83% below the high.
₪0.43+₪0.01 (+1.65%)
Cannassure Therapeutics Ltd’s quoted price sits in the upper half of its reported 52-week range, 19.85% below the high.
₪0.30-₪0.02 (-5.45%)
Human Xtensions Ltd.’s quoted price sits in the upper half of its reported 52-week range, 44.02% below the high.
₪2.68-₪0.16 (-5.64%)
Erech Finance Cahalacha Ltd’s quoted price sits in the lower half of its reported 52-week range, 70.04% below the high.
₪0.47-₪0.02 (-4.08%)
Nextgen Biomed Ltd’s quoted price sits in the upper half of its reported 52-week range, 43.17% below the high.
₪0.90₪0.00 (0.0%)
Canzon Israel Ltd’s quoted price sits in the lower half of its reported 52-week range, 58.9% below the high.
